Skip to main content
Erschienen in: Clinical Research in Cardiology 10/2016

29.06.2016 | Review

Cardiac surgery 2015 reviewed

verfasst von: Torsten Doenst, Constanze Strüning, Alexandros Moschovas, David Gonzalez-Lopez, Yasin Essa, Hristo Kirov, Mahmoud Diab, Gloria Faerber

Erschienen in: Clinical Research in Cardiology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

For the year 2015, almost 19,000 published references can be found in PubMed when entering the search term “cardiac surgery”. The last year has been again characterized by lively discussions in the fields where classic cardiac surgery and modern interventional techniques overlap. Lacking evidence in the field of coronary revascularization with either percutaneous coronary intervention or bypass surgery has been added. As in the years before, CABG remains the gold standard for the revascularization of complex stable triple-vessel disease. Plenty of new information has been presented comparing the conventional to transcatheter aortic valve implantation (TAVI) demonstrating similar short- and mid-term outcomes at high and low risk, but even a survival advantage with transfemoral TAVI at intermediate risk. In addition, there were many relevant and interesting other contributions from the purely operative arena. This review article will summarize the most pertinent publications in the fields of coronary revascularization, surgical treatment of valve disease, heart failure (i.e., transplantation and ventricular assist devices), and aortic surgery. While the article does not have the expectation of being complete and cannot be free of individual interpretation, it provides a condensed summary that is intended to give the reader “solid ground” for up-to-date decision-making in cardiac surgery.
Literatur
1.
Zurück zum Zitat Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Kim WS, Lee YT, Gwon HC (2015) Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv 8(2):271–279. doi:10.1016/j.jcin.2014.10.010 CrossRefPubMed Jang WJ, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Kim WS, Lee YT, Gwon HC (2015) Long-term survival benefit of revascularization compared with medical therapy in patients with coronary chronic total occlusion and well-developed collateral circulation. JACC Cardiovasc Interv 8(2):271–279. doi:10.​1016/​j.​jcin.​2014.​10.​010 CrossRefPubMed
2.
Zurück zum Zitat Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL (2014) Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 174(2):232–240. doi:10.1001/jamainternmed.2013.12855 CrossRefPubMed Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, Hardison RM, Abbott JD, Brown DL (2014) Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med 174(2):232–240. doi:10.​1001/​jamainternmed.​2013.​12855 CrossRefPubMed
3.
Zurück zum Zitat Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW (2015) Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation 131(14):1269–1277. doi:10.1161/CIRCULATIONAHA.114.013042 CrossRefPubMed Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW (2015) Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation 131(14):1269–1277. doi:10.​1161/​CIRCULATIONAHA.​114.​013042 CrossRefPubMed
4.
Zurück zum Zitat Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK, Investigators BT (2015) Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372(13):1204–1212. doi:10.1056/NEJMoa1415447 CrossRefPubMed Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK, Investigators BT (2015) Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med 372(13):1204–1212. doi:10.​1056/​NEJMoa1415447 CrossRefPubMed
5.
6.
Zurück zum Zitat Habib RH, Dimitrova KR, Badour SA, Yammine MB, El-Hage-Sleiman AK, Hoffman DM, Geller CM, Schwann TA, Tranbaugh RF (2015) CABG versus PCI: greater benefit in long-term outcomes with multiple arterial bypass grafting. J Am Coll Cardiol 66(13):1417–1427. doi:10.1016/j.jacc.2015.07.060 CrossRefPubMed Habib RH, Dimitrova KR, Badour SA, Yammine MB, El-Hage-Sleiman AK, Hoffman DM, Geller CM, Schwann TA, Tranbaugh RF (2015) CABG versus PCI: greater benefit in long-term outcomes with multiple arterial bypass grafting. J Am Coll Cardiol 66(13):1417–1427. doi:10.​1016/​j.​jacc.​2015.​07.​060 CrossRefPubMed
7.
Zurück zum Zitat Kikuchi K, Une D, Kurata A, Ruel M (2015) Off-pump minimally invasive coronary artery bypass grafting using the bilateral internal thoracic arteries and the right gastroepiproic artery. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv281 PubMed Kikuchi K, Une D, Kurata A, Ruel M (2015) Off-pump minimally invasive coronary artery bypass grafting using the bilateral internal thoracic arteries and the right gastroepiproic artery. Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezv281 PubMed
8.
Zurück zum Zitat Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2015) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial. JACC Cardiovasc Interv 8(1 Pt A):30–38. doi:10.1016/j.jcin.2014.08.006 CrossRefPubMed Blazek S, Rossbach C, Borger MA, Fuernau G, Desch S, Eitel I, Stiermaier T, Lurz P, Holzhey D, Schuler G, Mohr FW, Thiele H (2015) Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of a randomized trial. JACC Cardiovasc Interv 8(1 Pt A):30–38. doi:10.​1016/​j.​jcin.​2014.​08.​006 CrossRefPubMed
9.
Zurück zum Zitat Deppe AC, Liakopoulos OJ, Kuhn EW, Slottosch I, Scherner M, Choi YH, Rahmanian PB, Wahlers T (2015) Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease: a meta-analysis of 2885 patients. Eur J Cardiothorac Surg 47(3):397–406. doi:10.1093/ejcts/ezu285 (discussion 406) CrossRefPubMed Deppe AC, Liakopoulos OJ, Kuhn EW, Slottosch I, Scherner M, Choi YH, Rahmanian PB, Wahlers T (2015) Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease: a meta-analysis of 2885 patients. Eur J Cardiothorac Surg 47(3):397–406. doi:10.​1093/​ejcts/​ezu285 (discussion 406) CrossRefPubMed
10.
Zurück zum Zitat Harskamp RE, Vassiliades TA, Mehta RH, de Winter RJ, Lopes RD, Xian Y, Peterson ED, Puskas JD, Halkos ME (2015) Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting. J Am Coll Surg 221(2):326 e321–334 e321. doi:10.1016/j.jamcollsurg.2015.03.012 CrossRef Harskamp RE, Vassiliades TA, Mehta RH, de Winter RJ, Lopes RD, Xian Y, Peterson ED, Puskas JD, Halkos ME (2015) Comparative effectiveness of hybrid coronary revascularization vs coronary artery bypass grafting. J Am Coll Surg 221(2):326 e321–334 e321. doi:10.​1016/​j.​jamcollsurg.​2015.​03.​012 CrossRef
11.
Zurück zum Zitat Raja SG, Benedetto U, Alkizwini E, Gupta S, Amrani M, Harefield Cardiac Outcomes Research G (2015) Propensity score adjusted comparison of MIDCAB versus full sternotomy left anterior descending artery revascularization. Innovations 10(3):174–178. doi:10.1097/IMI.0000000000000162 PubMed Raja SG, Benedetto U, Alkizwini E, Gupta S, Amrani M, Harefield Cardiac Outcomes Research G (2015) Propensity score adjusted comparison of MIDCAB versus full sternotomy left anterior descending artery revascularization. Innovations 10(3):174–178. doi:10.​1097/​IMI.​0000000000000162​ PubMed
12.
Zurück zum Zitat Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, de Winter RJ, Vassiliades TA, Puskas JD, Halkos ME (2015) Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2015.10.061 PubMed Rosenblum JM, Harskamp RE, Hoedemaker N, Walker P, Liberman HA, de Winter RJ, Vassiliades TA, Puskas JD, Halkos ME (2015) Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts. J Thorac Cardiovasc Surg. doi:10.​1016/​j.​jtcvs.​2015.​10.​061 PubMed
16.
Zurück zum Zitat Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D (2015) The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg 150(4):880–888. doi:10.1016/j.jtcvs.2015.07.027 CrossRefPubMed Samano N, Geijer H, Liden M, Fremes S, Bodin L, Souza D (2015) The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg 150(4):880–888. doi:10.​1016/​j.​jtcvs.​2015.​07.​027 CrossRefPubMed
17.
Zurück zum Zitat Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, Kowalkowska ME, Zaborowska K, Navarese EP, Kolodziejczak M, Kowalewski J, Tarelli G, Taggart DP, Anisimowicz L (2016) Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg 151(1):60 e58–77 e58. doi:10.1016/j.jtcvs.2015.08.042 CrossRef Kowalewski M, Pawliszak W, Malvindi PG, Bokszanski MP, Perlinski D, Raffa GM, Kowalkowska ME, Zaborowska K, Navarese EP, Kolodziejczak M, Kowalewski J, Tarelli G, Taggart DP, Anisimowicz L (2016) Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg 151(1):60 e58–77 e58. doi:10.​1016/​j.​jtcvs.​2015.​08.​042 CrossRef
18.
Zurück zum Zitat Altarabsheh SE, Deo SV, Rababa’h AM, Lim JY, Cho YH, Sharma V, Jung SH, Shin E, Markowitz AH, Park SJ (2015) Off-pump coronary artery bypass reduces early stroke in octogenarians: a meta-analysis of 18,000 patients. Ann Thorac Surg 99(5):1568–1575. doi:10.1016/j.athoracsur.2014.12.057 CrossRefPubMed Altarabsheh SE, Deo SV, Rababa’h AM, Lim JY, Cho YH, Sharma V, Jung SH, Shin E, Markowitz AH, Park SJ (2015) Off-pump coronary artery bypass reduces early stroke in octogenarians: a meta-analysis of 18,000 patients. Ann Thorac Surg 99(5):1568–1575. doi:10.​1016/​j.​athoracsur.​2014.​12.​057 CrossRefPubMed
19.
Zurück zum Zitat Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.1093/eurheartj/ehu213 CrossRefPubMed Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Stahle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW (2014) Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J 35(40):2821–2830. doi:10.​1093/​eurheartj/​ehu213 CrossRefPubMed
20.
Zurück zum Zitat Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, Investigators S (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607–1616. doi:10.1056/NEJMoa1100356 CrossRefPubMedPubMedCentral Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G, Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC, O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH, Rouleau JL, Investigators S (2011) Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 364(17):1607–1616. doi:10.​1056/​NEJMoa1100356 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL, Investigators S (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374(16):1511–1520. doi:10.1056/NEJMoa1602001 CrossRefPubMed Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL, Investigators S (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374(16):1511–1520. doi:10.​1056/​NEJMoa1602001 CrossRefPubMed
22.
Zurück zum Zitat Bonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Investigators ST (2015) Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization. JACC Cardiovasc Imaging 8(10):1121–1129. doi:10.1016/j.jcmg.2015.03.013 CrossRefPubMed Bonow RO, Castelvecchio S, Panza JA, Berman DS, Velazquez EJ, Michler RE, She L, Holly TA, Desvigne-Nickens P, Kosevic D, Rajda M, Chrzanowski L, Deja M, Lee KL, White H, Oh JK, Doenst T, Hill JA, Rouleau JL, Menicanti L, Investigators ST (2015) Severity of remodeling, myocardial viability, and survival in ischemic LV dysfunction after surgical revascularization. JACC Cardiovasc Imaging 8(10):1121–1129. doi:10.​1016/​j.​jcmg.​2015.​03.​013 CrossRefPubMed
23.
Zurück zum Zitat MacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan RS, Lee KL, Miller AB, Sopko G, Szalewska D, Waclawiw MA, Dabrowski R, Castelvecchio S, Adlbrecht C, Michler RE, Oh JK, Velazquez EJ, Petrie MC (2015) Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail 17(7):725–734. doi:10.1002/ejhf.288 CrossRefPubMedPubMedCentral MacDonald MR, She L, Doenst T, Binkley PF, Rouleau JL, Tan RS, Lee KL, Miller AB, Sopko G, Szalewska D, Waclawiw MA, Dabrowski R, Castelvecchio S, Adlbrecht C, Michler RE, Oh JK, Velazquez EJ, Petrie MC (2015) Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Eur J Heart Fail 17(7):725–734. doi:10.​1002/​ejhf.​288 CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Jolicoeur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC, Stewart R, Jhund PS, Desvigne-Nickens P, Panza JA, Bonow RO, Sun B, San TR, Al-Khalidi HR, Rouleau JL, Velazquez EJ, Cleland JG (2015) Importance of Angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. J Am Coll Cardiol 66(19):2092–2100. doi:10.1016/j.jacc.2015.08.882 CrossRefPubMed Jolicoeur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC, Stewart R, Jhund PS, Desvigne-Nickens P, Panza JA, Bonow RO, Sun B, San TR, Al-Khalidi HR, Rouleau JL, Velazquez EJ, Cleland JG (2015) Importance of Angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. J Am Coll Cardiol 66(19):2092–2100. doi:10.​1016/​j.​jacc.​2015.​08.​882 CrossRefPubMed
25.
Zurück zum Zitat Davierwala PM, Verevkin A, Leontyev S, Misfeld M, Borger MA, Mohr FW (2015) Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction? Circulation 132(8):731–740. doi:10.1161/CIRCULATIONAHA.115.015279 CrossRefPubMed Davierwala PM, Verevkin A, Leontyev S, Misfeld M, Borger MA, Mohr FW (2015) Does timing of coronary artery bypass surgery affect early and long-term outcomes in patients with non-ST-segment-elevation myocardial infarction? Circulation 132(8):731–740. doi:10.​1161/​CIRCULATIONAHA.​115.​015279 CrossRefPubMed
26.
28.
Zurück zum Zitat Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG, Investigators Pt (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484. doi:10.1016/S0140-6736(15)60308-7 CrossRefPubMed Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG, Investigators Pt (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484. doi:10.​1016/​S0140-6736(15)60308-7 CrossRefPubMed
29.
Zurück zum Zitat Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ (2015) 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66(2):113–121. doi:10.1016/j.jacc.2015.05.017 CrossRefPubMed Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Lee JS, Hermiller JB Jr, Chetcuti S, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte JV, Resar JR, Aharonian V, Pfeffer T, Oh JK, Qiao H, Popma JJ (2015) 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol 66(2):113–121. doi:10.​1016/​j.​jacc.​2015.​05.​017 CrossRefPubMed
30.
Zurück zum Zitat Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. doi:10.1056/NEJMoa1514616 CrossRefPubMed Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. doi:10.​1056/​NEJMoa1514616 CrossRefPubMed
31.
Zurück zum Zitat Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. doi:10.1016/S0140-6736(16)30073-3 PubMed Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. doi:10.​1016/​S0140-6736(16)30073-3 PubMed
32.
Zurück zum Zitat Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65(20):2184–2194. doi:10.1016/j.jacc.2015.03.014 CrossRefPubMed Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65(20):2184–2194. doi:10.​1016/​j.​jacc.​2015.​03.​014 CrossRefPubMed
33.
Zurück zum Zitat Tamburino C, Barbanti M, D’Errigo P, Ranucci M, Onorati F, Covello RD, Santini F, Rosato S, Santoro G, Fusco D, Grossi C, Seccareccia F, Group OR (2015) 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT Study. J Am Coll Cardiol 66(7):804–812. doi:10.1016/j.jacc.2015.06.013 CrossRefPubMed Tamburino C, Barbanti M, D’Errigo P, Ranucci M, Onorati F, Covello RD, Santini F, Rosato S, Santoro G, Fusco D, Grossi C, Seccareccia F, Group OR (2015) 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT Study. J Am Coll Cardiol 66(7):804–812. doi:10.​1016/​j.​jacc.​2015.​06.​013 CrossRefPubMed
34.
Zurück zum Zitat Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Mollmann H, Board GE (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY Registry. J Am Coll Cardiol 65(20):2173–2180. doi:10.1016/j.jacc.2015.03.034 CrossRefPubMed Walther T, Hamm CW, Schuler G, Berkowitsch A, Kotting J, Mangner N, Mudra H, Beckmann A, Cremer J, Welz A, Lange R, Kuck KH, Mohr FW, Mollmann H, Board GE (2015) Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY Registry. J Am Coll Cardiol 65(20):2173–2180. doi:10.​1016/​j.​jacc.​2015.​03.​034 CrossRefPubMed
35.
Zurück zum Zitat Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Moellmann H, Naber CK, Schunkert H, Thiele H, Hamm C (2015) Qualitaetskriterien zur Durchführung der transvaskulaeren Aortenklappenimplantation. Kardiologe 9:11–26. doi:10.1007/s12181-014-0622-8 CrossRef Kuck KH, Eggebrecht H, Figulla HR, Haude M, Katus H, Moellmann H, Naber CK, Schunkert H, Thiele H, Hamm C (2015) Qualitaetskriterien zur Durchführung der transvaskulaeren Aortenklappenimplantation. Kardiologe 9:11–26. doi:10.​1007/​s12181-014-0622-8 CrossRef
36.
Zurück zum Zitat Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM, Pichard AD, Makkar R, Williams M, Hahn RT, Xu K, Smith CR, Leon MB, Kodali SK, Office PP (2015) Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 101(20):1665–1671. doi:10.1136/heartjnl-2015-307666 CrossRefPubMed Dizon JM, Nazif TM, Hess PL, Biviano A, Garan H, Douglas PS, Kapadia S, Babaliaros V, Herrmann HC, Szeto WY, Jilaihawi H, Fearon WF, Tuzcu EM, Pichard AD, Makkar R, Williams M, Hahn RT, Xu K, Smith CR, Leon MB, Kodali SK, Office PP (2015) Chronic pacing and adverse outcomes after transcatheter aortic valve implantation. Heart 101(20):1665–1671. doi:10.​1136/​heartjnl-2015-307666 CrossRefPubMed
39.
Zurück zum Zitat De Marchena E, Mesa J, Pomenti S, Marin YKC, Marincic X, Yahagi K, Ladich E, Kutz R, Aga Y, Ragosta M, Chawla A, Ring ME, Virmani R (2015) Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(5):728–739. doi:10.1016/j.jcin.2015.03.005 CrossRefPubMed De Marchena E, Mesa J, Pomenti S, Marin YKC, Marincic X, Yahagi K, Ladich E, Kutz R, Aga Y, Ragosta M, Chawla A, Ring ME, Virmani R (2015) Thrombus formation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8(5):728–739. doi:10.​1016/​j.​jcin.​2015.​03.​005 CrossRefPubMed
40.
Zurück zum Zitat Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Sondergaard L (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373(21):2015–2024. doi:10.1056/NEJMoa1509233 CrossRefPubMed Makkar RR, Fontana G, Jilaihawi H, Chakravarty T, Kofoed KF, de Backer O, Asch FM, Ruiz CE, Olsen NT, Trento A, Friedman J, Berman D, Cheng W, Kashif M, Jelnin V, Kliger CA, Guo H, Pichard AD, Weissman NJ, Kapadia S, Manasse E, Bhatt DL, Leon MB, Sondergaard L (2015) Possible subclinical leaflet thrombosis in bioprosthetic aortic valves. N Engl J Med 373(21):2015–2024. doi:10.​1056/​NEJMoa1509233 CrossRefPubMed
41.
Zurück zum Zitat Doenst T, Amorim PA, Diab M, Hagendorff A, Faerber G, Graff J, Rastan A, Deutsch O, Eichinger W, Investigators PI (2014) Novel thoughts on patient-prosthesis mismatch in aortic valve replacement: the rationale for the PAR I trial. Thorac Cardiovasc Surg 62(6):463–468. doi:10.1055/s-0034-1377063 CrossRefPubMed Doenst T, Amorim PA, Diab M, Hagendorff A, Faerber G, Graff J, Rastan A, Deutsch O, Eichinger W, Investigators PI (2014) Novel thoughts on patient-prosthesis mismatch in aortic valve replacement: the rationale for the PAR I trial. Thorac Cardiovasc Surg 62(6):463–468. doi:10.​1055/​s-0034-1377063 CrossRefPubMed
42.
Zurück zum Zitat Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT (2015) Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36(7):449–456. doi:10.1093/eurheartj/ehu384 CrossRefPubMed Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT (2015) Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36(7):449–456. doi:10.​1093/​eurheartj/​ehu384 CrossRefPubMed
43.
Zurück zum Zitat Kodali S (2015) Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. Paper presented at the ACC Scientific Sessions, San Diego Kodali S (2015) Clinical and echocardiographic outcomes at 30 days with the SAPIEN 3 TAVR system in inoperable, high-risk and intermediate-risk AS patients. Paper presented at the ACC Scientific Sessions, San Diego
44.
Zurück zum Zitat Wendt D, Al-Rashid F, Kahlert P, Eissmann M, El-Chilali K, Janosi RA, Pasa S, Tsagakis K, Liakopoulos O, Erbel R, Jakob H, Thielmann M (2015) Low incidence of paravalvular leakage with the balloon-expandable Sapien 3 Transcatheter Heart Valve. Ann Thorac Surg 100(3):819–825. doi:10.1016/j.athoracsur.2015.03.079 (discussion 825–816) CrossRefPubMed Wendt D, Al-Rashid F, Kahlert P, Eissmann M, El-Chilali K, Janosi RA, Pasa S, Tsagakis K, Liakopoulos O, Erbel R, Jakob H, Thielmann M (2015) Low incidence of paravalvular leakage with the balloon-expandable Sapien 3 Transcatheter Heart Valve. Ann Thorac Surg 100(3):819–825. doi:10.​1016/​j.​athoracsur.​2015.​03.​079 (discussion 825–816) CrossRefPubMed
45.
Zurück zum Zitat Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ, CoreValve USPTCI (2015) Regression of paravalvular aortic regurgitation and remodeling of self-expanding transcatheter aortic valve: an observation from the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging 8(12):1364–1375. doi:10.1016/j.jcmg.2015.07.012 CrossRefPubMed Oh JK, Little SH, Abdelmoneim SS, Reardon MJ, Kleiman NS, Lin G, Bach D, Gillam L, Kar B, Coselli J, Sengupta PP, Grewal K, Chang J, Chang Y, Boulware M, Adams DH, Popma JJ, CoreValve USPTCI (2015) Regression of paravalvular aortic regurgitation and remodeling of self-expanding transcatheter aortic valve: an observation from the CoreValve U.S. Pivotal Trial. JACC Cardiovasc Imaging 8(12):1364–1375. doi:10.​1016/​j.​jcmg.​2015.​07.​012 CrossRefPubMed
46.
Zurück zum Zitat Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG (2015) Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131(22):1989–2000. doi:10.1161/CIRCULATIONAHA.114.012525 CrossRefPubMed Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG (2015) Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131(22):1989–2000. doi:10.​1161/​CIRCULATIONAHA.​114.​012525 CrossRefPubMed
47.
Zurück zum Zitat Merk DR, Lehmann S, Holzhey DM, Dohmen P, Candolfi P, Misfeld M, Mohr FW, Borger MA (2015) Minimal invasive aortic valve replacement surgery is associated with improved survival: a propensity-matched comparison. Eur J Cardiothorac Surg 47(1):11–17. doi:10.1093/ejcts/ezu068 (discussion 17) CrossRefPubMed Merk DR, Lehmann S, Holzhey DM, Dohmen P, Candolfi P, Misfeld M, Mohr FW, Borger MA (2015) Minimal invasive aortic valve replacement surgery is associated with improved survival: a propensity-matched comparison. Eur J Cardiothorac Surg 47(1):11–17. doi:10.​1093/​ejcts/​ezu068 (discussion 17) CrossRefPubMed
48.
Zurück zum Zitat Ghanta RK, Lapar DJ, Kern JA, Kron IL, Speir AM, Fonner E Jr, Quader M, Ailawadi G (2015) Minimally invasive aortic valve replacement provides equivalent outcomes at reduced cost compared with conventional aortic valve replacement: a real-world multi-institutional analysis. J Thorac Cardiovasc Surg 149(4):1060–1065. doi:10.1016/j.jtcvs.2015.01.014 CrossRefPubMedPubMedCentral Ghanta RK, Lapar DJ, Kern JA, Kron IL, Speir AM, Fonner E Jr, Quader M, Ailawadi G (2015) Minimally invasive aortic valve replacement provides equivalent outcomes at reduced cost compared with conventional aortic valve replacement: a real-world multi-institutional analysis. J Thorac Cardiovasc Surg 149(4):1060–1065. doi:10.​1016/​j.​jtcvs.​2015.​01.​014 CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Bowdish ME, Hui DS, Cleveland JD, Mack WJ, Sinha R, Ranjan R, Cohen RG, Baker CJ, Cunningham MJ, Barr ML, Starnes VA (2015) A comparison of aortic valve replacement via an anterior right minithoracotomy with standard sternotomy: a propensity score analysis of 492 patientsdagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv038 PubMed Bowdish ME, Hui DS, Cleveland JD, Mack WJ, Sinha R, Ranjan R, Cohen RG, Baker CJ, Cunningham MJ, Barr ML, Starnes VA (2015) A comparison of aortic valve replacement via an anterior right minithoracotomy with standard sternotomy: a propensity score analysis of 492 patientsdagger. Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezv038 PubMed
50.
Zurück zum Zitat Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, Quaini E, Solinas M, Berti S, Glauber M (2015) Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv210 Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, Quaini E, Solinas M, Berti S, Glauber M (2015) Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezv210
51.
Zurück zum Zitat Muneretto C, Alfieri O, Cesana BM, Bisleri G, De Bonis M, Di Bartolomeo R, Savini C, Folesani G, Di Bacco L, Rambaldini M, Maureira JP, Laborde F, Tespili M, Repossini A, Folliguet T (2015) A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in “real-world” patients with aortic stenosis and intermediate- to high-risk profile. J Thorac Cardiovasc Surg 150(6):1570–1579. doi:10.1016/j.jtcvs.2015.08.052 CrossRefPubMed Muneretto C, Alfieri O, Cesana BM, Bisleri G, De Bonis M, Di Bartolomeo R, Savini C, Folesani G, Di Bacco L, Rambaldini M, Maureira JP, Laborde F, Tespili M, Repossini A, Folliguet T (2015) A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in “real-world” patients with aortic stenosis and intermediate- to high-risk profile. J Thorac Cardiovasc Surg 150(6):1570–1579. doi:10.​1016/​j.​jtcvs.​2015.​08.​052 CrossRefPubMed
52.
Zurück zum Zitat Colli A, Marchetto G, Salizzoni S, Rinaldi M, Di Marco L, Pacini D, Di Bartolomeo R, Nicolini F, Gherli T, Agrifoglio M, Borghetti V, Khoury G, De Paolis M, Zoffoli G, Mangino D, Amorim MJ, Manzan E, Zucchetta F, Balduzzi S, Gerosa G (2015) The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation vs (C)arpentier Magna-Ease in (A)ortic positiondagger. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv070 Colli A, Marchetto G, Salizzoni S, Rinaldi M, Di Marco L, Pacini D, Di Bartolomeo R, Nicolini F, Gherli T, Agrifoglio M, Borghetti V, Khoury G, De Paolis M, Zoffoli G, Mangino D, Amorim MJ, Manzan E, Zucchetta F, Balduzzi S, Gerosa G (2015) The TRIBECA study: (TRI)fecta (B)ioprosthesis (E)valuation vs (C)arpentier Magna-Ease in (A)ortic positiondagger. Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezv070
53.
Zurück zum Zitat Borger MA, Moustafine V, Conradi L, Knosalla C, Richter M, Merk DR, Doenst T, Hammerschmidt R, Treede H, Dohmen P, Strauch JT (2015) A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 99(1):17–25. doi:10.1016/j.athoracsur.2014.09.022 CrossRefPubMed Borger MA, Moustafine V, Conradi L, Knosalla C, Richter M, Merk DR, Doenst T, Hammerschmidt R, Treede H, Dohmen P, Strauch JT (2015) A randomized multicenter trial of minimally invasive rapid deployment versus conventional full sternotomy aortic valve replacement. Ann Thorac Surg 99(1):17–25. doi:10.​1016/​j.​athoracsur.​2014.​09.​022 CrossRefPubMed
54.
Zurück zum Zitat Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M, Cavalier Trial I (2015) Clinical and haemodynamic outcomes in 658 patients receiving the perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezv257 Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M, Cavalier Trial I (2015) Clinical and haemodynamic outcomes in 658 patients receiving the perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg. doi:10.​1093/​ejcts/​ezv257
55.
Zurück zum Zitat Theron A, Gariboldi V, Grisoli D, Jaussaud N, Morera P, Lagier D, Leroux S, Amanatiou C, Guidon C, Riberi A, Collart F (2015) Rapid deployment of aortic bioprosthesis in elderly patients with small aortic annulus. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.09.024 PubMed Theron A, Gariboldi V, Grisoli D, Jaussaud N, Morera P, Lagier D, Leroux S, Amanatiou C, Guidon C, Riberi A, Collart F (2015) Rapid deployment of aortic bioprosthesis in elderly patients with small aortic annulus. Ann Thorac Surg. doi:10.​1016/​j.​athoracsur.​2015.​09.​024 PubMed
57.
Zurück zum Zitat Authors/Task Force M, Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM (2015) 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128. doi:10.1093/eurheartj/ehv319 CrossRef Authors/Task Force M, Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Document R, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM (2015) 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36(44):3075–3128. doi:10.​1093/​eurheartj/​ehv319 CrossRef
58.
Zurück zum Zitat Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, Schiller W, Gummert JF, Cremer JT (2015) Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. doi:10.1055/s-0035-1565257 Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, Schiller W, Gummert JF, Cremer JT (2015) Cardiac surgery in Germany during 2014: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg. doi:10.​1055/​s-0035-1565257
60.
Zurück zum Zitat Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152–1158CrossRefPubMed Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH (2000) Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol 36(4):1152–1158CrossRefPubMed
61.
Zurück zum Zitat Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U (2015) Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years. Eur Heart J. doi:10.1093/eurheartj/ehv580 PubMed Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U (2015) Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years. Eur Heart J. doi:10.​1093/​eurheartj/​ehv580 PubMed
62.
Zurück zum Zitat Koertke H, Zittermann A, Wagner O, Secer S, Christ of H, Sciangula A, Saggau W, Sack FU, Ennker J, Cremer J, Musumeci F, Gummert JF (2015) Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants. Eur Heart J 36(21):1297–1305. doi:10.1093/eurheartj/ehu330 CrossRefPubMed Koertke H, Zittermann A, Wagner O, Secer S, Christ of H, Sciangula A, Saggau W, Sack FU, Ennker J, Cremer J, Musumeci F, Gummert JF (2015) Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants. Eur Heart J 36(21):1297–1305. doi:10.​1093/​eurheartj/​ehu330 CrossRefPubMed
64.
65.
Zurück zum Zitat Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA, Ctsn (2015) Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. doi:10.1056/NEJMoa1512913 Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA, Ctsn (2015) Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. doi:10.​1056/​NEJMoa1512913
66.
Zurück zum Zitat Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O’Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O’Sullivan K, Parides MK, Swayze R, Thourani V, Rose EA, Perrault LP, Acker MA, Investigators C (2015) Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 149(3):752 e751–761 e751. doi:10.1016/j.jtcvs.2014.10.120 CrossRef Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O’Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O’Sullivan K, Parides MK, Swayze R, Thourani V, Rose EA, Perrault LP, Acker MA, Investigators C (2015) Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg 149(3):752 e751–761 e751. doi:10.​1016/​j.​jtcvs.​2014.​10.​120 CrossRef
67.
Zurück zum Zitat Samad Z, Shaw LK, Phelan M, Ersboll M, Risum N, Al-Khalidi HR, Glower DD, Milano CA, Alexander JH, O’Connor CM, Wang A, Velazquez EJ (2015) Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J 36(40):2733–2741. doi:10.1093/eurheartj/ehv343 CrossRefPubMed Samad Z, Shaw LK, Phelan M, Ersboll M, Risum N, Al-Khalidi HR, Glower DD, Milano CA, Alexander JH, O’Connor CM, Wang A, Velazquez EJ (2015) Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. Eur Heart J 36(40):2733–2741. doi:10.​1093/​eurheartj/​ehv343 CrossRefPubMed
68.
Zurück zum Zitat Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2015) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. doi:10.1093/eurheartj/ehv627 PubMedPubMedCentral Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2015) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J. doi:10.​1093/​eurheartj/​ehv627 PubMedPubMedCentral
70.
Zurück zum Zitat Adamo M, Barbanti M, Curello S, Fiorina C, Chiari E, Chizzola G, Capodanno D, Tamburino C, Metra M, Ettori F (2015) Effectiveness of MitraClip therapy in patients with refractory heart failure. J Interv Cardiol 28(1):61–68. doi:10.1111/joic.12179 CrossRefPubMed Adamo M, Barbanti M, Curello S, Fiorina C, Chiari E, Chizzola G, Capodanno D, Tamburino C, Metra M, Ettori F (2015) Effectiveness of MitraClip therapy in patients with refractory heart failure. J Interv Cardiol 28(1):61–68. doi:10.​1111/​joic.​12179 CrossRefPubMed
71.
Zurück zum Zitat Ansari MT, Ahmadzai N, Coyle K, Coyle D, Moher D (2015) Mitral valve clip for treatment of mitral regurgitation: an evidence-based analysis. Ont Health Technol Assess Ser 15(12):1–104PubMedPubMedCentral Ansari MT, Ahmadzai N, Coyle K, Coyle D, Moher D (2015) Mitral valve clip for treatment of mitral regurgitation: an evidence-based analysis. Ont Health Technol Assess Ser 15(12):1–104PubMedPubMedCentral
72.
Zurück zum Zitat Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170(5):1050 e1053–1059 e1053. doi:10.1016/j.ahj.2015.08.004 CrossRef Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170(5):1050 e1053–1059 e1053. doi:10.​1016/​j.​ahj.​2015.​08.​004 CrossRef
73.
Zurück zum Zitat Chikwe J, Itagaki S, Anyanwu A, Adams DH (2015) Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol 65(18):1931–1938. doi:10.1016/j.jacc.2015.01.059 CrossRefPubMed Chikwe J, Itagaki S, Anyanwu A, Adams DH (2015) Impact of concomitant tricuspid annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol 65(18):1931–1938. doi:10.​1016/​j.​jacc.​2015.​01.​059 CrossRefPubMed
74.
Zurück zum Zitat Moscarelli M, Fattouch K, Casula R, Speziale G, Lancellotti P, Athanasiou T (2015) What is the role of minimally invasive mitral valve surgery in high-risk patients? A meta-analysis of observational studies. Ann Thorac Surg. doi:10.1016/j.athoracsur.2015.08.050 PubMed Moscarelli M, Fattouch K, Casula R, Speziale G, Lancellotti P, Athanasiou T (2015) What is the role of minimally invasive mitral valve surgery in high-risk patients? A meta-analysis of observational studies. Ann Thorac Surg. doi:10.​1016/​j.​athoracsur.​2015.​08.​050 PubMed
75.
Zurück zum Zitat Ad N, Holmes SD, Shuman DJ, Pritchard G, Massimiano PS (2015) Minimally invasive mitral valve surgery without aortic cross-clamping and with femoral cannulation is not associated with increased risk of stroke compared with traditional mitral valve surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg 48(6):868–872. doi:10.1093/ejcts/ezv017 CrossRefPubMed Ad N, Holmes SD, Shuman DJ, Pritchard G, Massimiano PS (2015) Minimally invasive mitral valve surgery without aortic cross-clamping and with femoral cannulation is not associated with increased risk of stroke compared with traditional mitral valve surgery: a propensity score-matched analysis. Eur J Cardiothorac Surg 48(6):868–872. doi:10.​1093/​ejcts/​ezv017 CrossRefPubMed
76.
Zurück zum Zitat Elefteriades JA, Ziganshin BA, Rizzo JA, Fang H, Tranquilli M, Paruchuri V, Kuzmik G, Gubernikoff G, Dumfarth J, Charilaou P, Theodoropoulos P (2015) Indications and imaging for aortic surgery: size and other matters. J Thorac Cardiovasc Surg 149(2 Suppl):S10–S13. doi:10.1016/j.jtcvs.2014.07.066 CrossRefPubMed Elefteriades JA, Ziganshin BA, Rizzo JA, Fang H, Tranquilli M, Paruchuri V, Kuzmik G, Gubernikoff G, Dumfarth J, Charilaou P, Theodoropoulos P (2015) Indications and imaging for aortic surgery: size and other matters. J Thorac Cardiovasc Surg 149(2 Suppl):S10–S13. doi:10.​1016/​j.​jtcvs.​2014.​07.​066 CrossRefPubMed
77.
Zurück zum Zitat Itagaki S, Chikwe JP, Chiang YP, Egorova NN, Adams DH (2015) Long-term risk for aortic complications after aortic valve replacement in patients with bicuspid aortic valve versus Marfan syndrome. J Am Coll Cardiol 65(22):2363–2369. doi:10.1016/j.jacc.2015.03.575 CrossRefPubMed Itagaki S, Chikwe JP, Chiang YP, Egorova NN, Adams DH (2015) Long-term risk for aortic complications after aortic valve replacement in patients with bicuspid aortic valve versus Marfan syndrome. J Am Coll Cardiol 65(22):2363–2369. doi:10.​1016/​j.​jacc.​2015.​03.​575 CrossRefPubMed
78.
Zurück zum Zitat Shrestha M, Bachet J, Bavaria J, Carrel TP, De Paulis R, Di Bartolomeo R, Etz CD, Grabenwoger M, Grimm M, Haverich A, Jakob H, Martens A, Mestres CA, Pacini D, Resch T, Schepens M, Urbanski PP, Czerny M (2015) Current status and recommendations for use of the frozen elephant trunk technique: a position paper by the Vascular Domain of EACTS. Eur J Cardiothorac Surg 47(5):759–769. doi:10.1093/ejcts/ezv085 CrossRefPubMed Shrestha M, Bachet J, Bavaria J, Carrel TP, De Paulis R, Di Bartolomeo R, Etz CD, Grabenwoger M, Grimm M, Haverich A, Jakob H, Martens A, Mestres CA, Pacini D, Resch T, Schepens M, Urbanski PP, Czerny M (2015) Current status and recommendations for use of the frozen elephant trunk technique: a position paper by the Vascular Domain of EACTS. Eur J Cardiothorac Surg 47(5):759–769. doi:10.​1093/​ejcts/​ezv085 CrossRefPubMed
79.
Zurück zum Zitat Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, Investigators PIt (2015) Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 385(9987):2577–2584. doi:10.1016/S0140-6736(15)60261-6 CrossRefPubMed Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, Investigators PIt (2015) Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial. Lancet 385(9987):2577–2584. doi:10.​1016/​S0140-6736(15)60261-6 CrossRefPubMed
81.
82.
Zurück zum Zitat Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirajan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG, Investigators RS (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results From the ROADMAP Study. J Am Coll Cardiol 66(16):1747–1761. doi:10.1016/j.jacc.2015.07.075 CrossRefPubMed Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirajan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG, Investigators RS (2015) Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results From the ROADMAP Study. J Am Coll Cardiol 66(16):1747–1761. doi:10.​1016/​j.​jacc.​2015.​07.​075 CrossRefPubMed
83.
Zurück zum Zitat Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD (2015) Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol 66(23):2579–2589. doi:10.1016/j.jacc.2015.09.083 CrossRefPubMed Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Marasco S, Beyersdorf F, Damme L, Schmitto JD (2015) Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study. J Am Coll Cardiol 66(23):2579–2589. doi:10.​1016/​j.​jacc.​2015.​09.​083 CrossRefPubMed
Metadaten
Titel
Cardiac surgery 2015 reviewed
verfasst von
Torsten Doenst
Constanze Strüning
Alexandros Moschovas
David Gonzalez-Lopez
Yasin Essa
Hristo Kirov
Mahmoud Diab
Gloria Faerber
Publikationsdatum
29.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 10/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1013-x

Weitere Artikel der Ausgabe 10/2016

Clinical Research in Cardiology 10/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.